Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

In this Huberman Lab Essentials episode, my guest is Dr. Matthew
Johnson, PhD, a senior researcher for the Center of Excellence for
Psilocybin Research and Treatment at Sheppard Pratt’s Institute for
Advanced Diagnostics and Therapeutics. We explore the science and
therapeutic potential of psychedelic medicine, including
psilocybin, MDMA and LSD. We discuss how these substances can
profoundly alter perception and self-identity, providing
long-lasting relief from depression, addiction and trauma when used
in controlled clinical settings. We also discuss microdosing and
emerging research on psychedelics’ potential to support recovery
from neurological injuries. Read the episode show notes at
hubermanlab.com. Thank you to our sponsors AG1:
https://drinkag1.com/huberman David:
https://davidprotein.com/huberman BetterHelp:
https://betterhelp.com/huberman Timestamps 00:00:00 Matthew
Johnson; Psychedelics 00:01:44 Different Classes of Psychedelics
00:04:33 Psychedelics & Altering Models 00:06:18 Sponsor: David
00:07:33 LSD, Psylocibin & Serotonin 00:09:55 Psychedelic
Clinical Trials 00:13:40 Therapy, Trust, Psychedelics 00:16:47
Letting Go & Psychedelic Experience, Self-Representation,
Lasting Changes 00:22:31 Sponsors: AG1 & BetterHelp 00:25:26
MDMA, Dopamine & Serotonin; Bad Trips & Transcendental
Experience 00:28:49 Dangers of Psychedelics 00:31:11 Microdosing
Psychedelics, Antidepressant 00:35:27 Head Injuries, Psychedelics,
Depression 00:38:29 Acknowledgements Disclaimer & Disclosures
Learn more about your ad choices. Visit megaphone.fm/adchoices